If results hold in September then the FDA may act on humanitarian grounds. If that happens an avalanche of buying is certain. Yes, it is a long shot but this CNS disorder story is compelling and it will drive action not seen before. Any prediction of future timelines based on historical precident is flawed.
I own both and feel this has been yet another example of market corruption. Yes, I know, it is what it is but this has been an obvious drive out the retailer and lay in the weeds to pounce as it recovers. If AVXL fails because the science failed then I guess I can live with that but being screwed by a system driven solely by market corruption really pixxes me off.
Well done...these are all clinical-dynamically linked activities which at some point begin to cross link the validations for new treatment thinking. Is it possible that CNS disorders have some common root causes? Explosive concepts.
The smartest guy I ever knew (Dr Peter Senge-MIT-Systems Dynamics, etal) used to say that he took it as an act of faith that 1+1 actually = 2.
Yes, exactly correct. You should wait and wait until it goes so low you feel it is safe to buy. Let us know how that works oout for you.
I agree, the Bio_Pharma vs Chem_Pharma battle is about to play out. Lots of good news IMO, proving efficacy should be a lot less obtuse and expensive. If AVXL has the goods then it will be obvious, early on. Others in the wings .
I own both and continue to hold AVXL to comfort myself during NVIV recent regression, which I expect to reverse any day now. Not an either or for me. All the best.
88...agree, MJF grant is multiple blessings. Not only do they fund the trials but they give their name. Micro Bios like AVXL are golden when this kind of recognition is given. In some way it adds to the credibility of the entire effort and the development team. If we are real lucky the trials show no/low risk and promise of high efficacy. Many positives.
I am long as well, big P may be history if BioPharma is shown to work more effectively than ChemPharma. I think that may be what we are seeing. They relly have no options. If they keep dropping bilions in research that goes nowhere they are toast.
rocket, I have read the trial expansion comment several times and think that it is important. When patients/families (study participants) ask to have their trial extended it says a lot to me. We would normally be at the exclusive mercy of clinicians who study/review assess the trial data and usually and tell us what is happening, that is as good as it gets. Do not want read too much into this but have never seen patient comments before and I like it. Of course they are human and could be mistaken but my guess is they know when they feel better. A positive observation.